|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue, net | |||||
| Product | |||||
| Service | |||||
| Total revenue, net | |||||
| Cost of sales | |||||
| Product | |||||
| Service | |||||
| Total cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income (expense), net (Notes 11, 12) | |||||
| Interest income | |||||
| Other income, net | |||||
| Total other income, net | |||||
| Loss before income taxes | |||||
| Provision for (benefit from) income taxes | |||||
| Net loss | |||||
| Foreign currency translation adjustment, net of tax | |||||
| Unrealized gain (loss) on marketable securities | |||||
| Net comprehensive loss | |||||
| Less: net loss allocated to noncontrolling interests | |||||
| Less: net income allocated to participating securities | |||||
| Net loss attributable to common stockholders, basic | |||||
| Net loss attributable to common stockholders, diluted | |||||
| Net loss attributable to common stockholders per share, basic (in dollars per share) | |||||
| Net loss attributable to common stockholders per share, diluted (in dollars per share) | |||||
| Weighted-average shares used in calculating net loss per share, basic (in shares) | |||||
| Weighted-average shares used in calculating net loss per share, diluted (in shares) | |||||
Loading...